Exela Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EXELA PHARMA, and what generic alternatives to EXELA PHARMA drugs are available?
EXELA PHARMA has twenty-three approved drugs.
There are seventeen US patents protecting EXELA PHARMA drugs.
Drugs and US Patents for Exela Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exela Pharma | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 204797-001 | Apr 15, 2021 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Exela Pharma | AKOVAZ | ephedrine sulfate | SOLUTION;INTRAVENOUS | 208289-002 | Aug 2, 2021 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Exela Pharma | SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 211091-003 | Jun 20, 2019 | AP | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Exela Pharma | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-002 | Jun 27, 2014 | AP1 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Exela Pharma | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 018925-001 | Mar 30, 1984 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.